No Data
Emerging markets stock digest: Brightpass surged significantly, Basefood temporarily hit the daily limit up.
<5070> Draft 545 +9 continued to rise. After the close of trading on the 25th, they announced an upward revision of financial estimates and a change in dividend policy, which is considered a positive factor. The company has been emphasizing the stable return of profits to shareholders, and has been continuing its progressive dividends since its listing. As a result of conducting progressive dividends regardless of the level of consolidated net income, the fluctuation range of dividend payout ratios in the past five periods has been 8.1% to 238.1%. In light of this situation, they will continue to do so regardless of the level of consolidated net income in the future.
Draft---Upward revision of dividend financial estimates and changes in dividend policy.
Draft <5070> announced the revision (increase) of the dividend forecast for the fiscal year ending December 2024 and a change in dividend policy on the 25th. The company has been emphasizing the stable return of profits to shareholders and has continued to increase dividends since its listing. As a result of the progressive dividend regardless of the level of consolidated net income, the volatility of the dividend payout ratio over the past five periods (from the fiscal year ended March 2020 to the fiscal year ended December 2023) ranged from 8.1% to 238.1%. In view of this situation, dividends will continue to be progressive regardless of the level of consolidated net income in the future.
Draft: Notice regarding revisions to dividend forecasts (dividend increases) and changes in dividend policies
OpenAI to open office in New York.
[Office] OpenAI, which is behind the "Chat GPT", is reported to be opening its first office in New York City. Among office building owners, there are reports of high expectations for the increasing demand for office spaces in the rapidly growing AI industry. Other AI giants like Anzotropic and Palantir also seem to be securing office spaces in New York, the San Francisco Bay Area, Denver, Atlanta, and Seattle. <
Draft Research Memo (10): Revenue reached 55.7% of the annual target as of the second quarter (1).
■ Draft <5070> Mid-term Management Plan 1. In the mid-term management plan (from December 2024 to December 2026), the target for the final year of December 2026 is a revenue of 14.5 billion yen and an operating margin of 9%. In addition to the increase in net income due to achieving this goal, the company aims to achieve sustainable growth, expand profits, improve brand value, increase the p/e ratio, and enhance the market valuation of the company. The market capitalization is expected to increase from 7.1 billion yen as of December 2023.
Draft Research Memo (9): The target revenue for the fiscal year ending December 2024 will remain at 12,000 million yen.
■ Outlook for Draft <5070> ● Financial forecast for the year ending December 2024 The consolidated financial performance for the year ending December 2024 is expected to be 1.2 billion yen, a 12.1% increase in revenue compared to the previous year, 980 million yen, a 12.6% increase in operating profit, 960 million yen, a 13.2% increase in ordinary profit, and 580 million yen, a 12.3% increase in net income attributable to the parent company's shareholders, and it is the same as the initial forecast announced in February 2024. The company group as of the end of December 2023.
No Data
No Data
